Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.


  • Gene variants involved in stress responses affect 'post-concussive' symptoms

  • Tracing a path toward neuronal cell death

  • Income-based school assignment policy influences diversity, achievement

  • Low sugar diet makes foods taste sweeter but does not change preferred level of sweetness

  • Reduced blood flow seen in brain after clinical recovery of acute concussion

  • Newly evolved, uniquely human gene variants protect older adults from cognitive decline

  • Parental absence affects brain development in children

  • Aspirin targets key protein in neurodegenerative diseases

  • Could fish have consciousness? 'Emotional fever' experiment suggests they might

  • Threats against children during the separation process for women in abusive relationships